SciDev.Net

As tuberculosis strains that are resistant to all known drugs continue to emerge, scientists are trying new approaches to drug development.

Text messaging to ensure that TB patients in developing countries take their medication every day is showing promise in trials.

Leading geneticist Samir Brahmachari explains why India should kickstart a new open source approach to drug discovery for diseases like TB.

Bovine tuberculosis is no less dangerous to humans than common TB, but relatively little is known about it, reports Natasha Bolognesi.

Priya Shetty looks at the prevalence and distribution of tuberculosis in the developing world, outlining the truths — and myths — about this disease.

Jill McGivering and Ed Cropley report on how fake drugs and poor education increase resistance to antimalarials in South-East Asia.

The division between global programmes to fight TB and HIV is undermining the fight against the two diseases — but there are signs of change, reports Apoorva Mandavilli.